Semler Scientific to Report Second Quarter and First Half of 2024 Financial Results and Host Conference Call on August 5, 2024
Semler Scientific (Nasdaq: SMLR), a company focused on developing technology solutions for chronic disease management in healthcare, has announced its plans to report financial results for Q2 and H1 2024 on August 5, 2024, after U.S. market close. The company will host a conference call at 4:30 pm ET on the same day, led by CEO Doug Murphy-Chutorian, with participation from Chairman Eric Semler, CFO Renae Cormier, and COO Jennifer Oliva-Herrington.
Investors are encouraged to submit questions in advance to ir@semlerscientific.com and pre-register for the call. Those unable to pre-register can dial in using provided domestic and international numbers. The call will be archived on Semler Scientific's website for future reference.
Semler Scientific (Nasdaq: SMLR), un'azienda focalizzata nello sviluppo di soluzioni tecnologiche per la gestione delle malattie croniche nel settore sanitario, ha annunciato i suoi piani di pubblicare i risultati finanziari per il secondo trimestre e il primo semestre del 2024 il 5 agosto 2024, dopo la chiusura del mercato statunitense. L'azienda ospiterà una conferenza telefonica alle 4:30 pm ET lo stesso giorno, guidata dal CEO Doug Murphy-Chutorian, con la partecipazione del Presidente Eric Semler, del CFO Renae Cormier e del COO Jennifer Oliva-Herrington.
Si incoraggiano gli investitori a inviare domande in anticipo a ir@semlerscientific.com e a pre-registrarsi per la chiamata. Coloro che non possono pre-registrarsi possono chiamare utilizzando i numeri forniti per le chiamate nazionali e internazionali. La chiamata sarà archiviata sul sito web di Semler Scientific per riferimento futuro.
Semler Scientific (Nasdaq: SMLR), una empresa enfocada en desarrollar soluciones tecnológicas para la gestión de enfermedades crónicas en el cuidado de la salud, ha anunciado sus planes de informar sobre los resultados financieros del segundo trimestre y del primer semestre de 2024 el 5 de agosto de 2024, después del cierre del mercado estadounidense. La empresa llevará a cabo una llamada de conferencia a las 4:30 pm ET el mismo día, dirigida por el CEO Doug Murphy-Chutorian, con la participación del Presidente Eric Semler, la CFO Renae Cormier y la COO Jennifer Oliva-Herrington.
Se alienta a los inversores a enviar preguntas con antelación a ir@semlerscientific.com y a preinscribirse para la llamada. Aquellos que no puedan preinscribirse pueden conectarse utilizando los números nacionales e internacionales proporcionados. La llamada será archivada en el sitio web de Semler Scientific para referencia futura.
Semler Scientific (나스닥: SMLR)은 만성 질환 관리를 위한 기술 솔루션 개발에 집중하는 회사로, 2024년 2분기 및 상반기 재무 결과를 2024년 8월 5일 미국 시장 종료 후 발표할 계획이라고 발표했습니다. 같은 날 오후 4시 30분 ET에 CEO Doug Murphy-Chutorian이 이끄는 전화 회의가 열리며, 의장 Eric Semler, CFO Renae Cormier, COO Jennifer Oliva-Herrington도 참석할 예정입니다.
투자자들은 미리 ir@semlerscientific.com으로 질문을 제출하고, 통화에 사전 등록할 것을 권장합니다. 사전 등록이 불가능한 경우 제공된 국내 및 국제 전화번호로 접속할 수 있습니다. 이 통화는 Semler Scientific의 웹사이트에 나중에 참조할 수 있도록 보관됩니다.
Semler Scientific (Nasdaq: SMLR), une entreprise spécialisée dans le développement de solutions technologiques pour la gestion des maladies chroniques dans le secteur de la santé, a annoncé ses projets de publier les résultats financiers du 2e trimestre et du 1er semestre 2024 le 5 août 2024, après la fermeture du marché américain. L'entreprise organisera une conférence téléphonique à 16h30 ET le même jour, animée par le PDG Doug Murphy-Chutorian, avec la participation du Président Eric Semler, du CFO Renae Cormier et du COO Jennifer Oliva-Herrington.
Les investisseurs sont encouragés à soumettre des questions à l'avance à ir@semlerscientific.com et à se préinscrire pour l'appel. Ceux qui ne peuvent pas se préinscrire peuvent se connecter en utilisant les numéros nationaux et internationaux fournis. L'appel sera archivé sur le site web de Semler Scientific pour référence future.
Semler Scientific (Nasdaq: SMLR), ein Unternehmen, das sich auf die Entwicklung technologischer Lösungen für das Management chronischer Krankheiten im Gesundheitswesen spezialisiert hat, hat angekündigt, die Finanzergebnisse für das 2. Quartal und das 1. Halbjahr 2024 am 5. August 2024 nach dem Börsenschluss in den USA zu veröffentlichen. Das Unternehmen wird am selben Tag um 16:30 Uhr ET eine Telefonkonferenz abhalten, die vom CEO Doug Murphy-Chutorian geleitet wird, mit Teilnahme von Chairman Eric Semler, CFO Renae Cormier und COO Jennifer Oliva-Herrington.
Investoren werden ermutigt, Fragen im Voraus an ir@semlerscientific.com zu senden und sich für den Anruf vorzuregistrieren. Diejenigen, die sich nicht vorregistrieren können, können sich über die bereitgestellten nationalen und internationalen Nummern einwählen. Der Anruf wird zur späteren Einsichtnahme auf der Website von Semler Scientific archiviert.
- None.
- None.
We encourage participants to pre-register for the conference call using the following link: https://dpregister.com/sreg/10190580/fcfdde76dc. Callers who pre-register will be given a conference passcode and unique PIN to gain immediate access to the call and bypass the live operator. Participants may pre-register at any time, including up to and after the call start time.
Those without internet access or unable to pre-register may dial in by calling:
Domestic callers: 833-816-1161
International callers: 412-317-0717
Please specify to the operator that you would like to join the "Semler Scientific Call." The conference call will be archived on Semler Scientific's website at www.semlerscientific.com.
About Semler Scientific, Inc.:
Semler Scientific, Inc. develops, manufactures and markets innovative products and services to combat chronic diseases. Its flagship product, QuantaFlo®, which is patented and cleared by the
CONTACT:
Renae Cormier, CFO
ir@semlerscientific.com
View original content to download multimedia:https://www.prnewswire.com/news-releases/semler-scientific-to-report-second-quarter-and-first-half-of-2024-financial-results-and-host-conference-call-on-august-5-2024-302203104.html
SOURCE Semler Scientific, Inc.
FAQ
When will Semler Scientific (SMLR) report its Q2 and H1 2024 financial results?
What time is Semler Scientific's (SMLR) Q2 2024 earnings conference call scheduled for?
Who will be hosting Semler Scientific's (SMLR) Q2 2024 earnings call?
How can investors submit questions for Semler Scientific's (SMLR) Q2 2024 earnings call?
